| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/30/2009 | US20090191260 Aerosol and use thereof |
| 07/30/2009 | US20090191249 Sheet substrates impregnated with aromatic releasing compositions and a method of delivery of aromatic releasing compositions |
| 07/30/2009 | US20090191187 Antibodies against interleukin-1 receptor and uses thereof |
| 07/30/2009 | US20090191117 Anti-Integrin Antibodies, Compositions, Methods and Uses |
| 07/30/2009 | CA2711887A1 Dihydro-1h-pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as s1p1 agonists |
| 07/30/2009 | CA2705251A1 Method for the preparation of morphine compounds |
| 07/29/2009 | EP2083014A2 Inhibitors of interleukin-1ß converting enzyme |
| 07/29/2009 | EP2083006A1 Oxadiazolones, processes for their preparation and their use as pharmaceuticals |
| 07/29/2009 | EP2082743A2 Inhibitors of GSK-3 and crystal structures of GSK-3beta protein and protein complexes |
| 07/29/2009 | EP2081932A2 2-o'-methyladenosine derivatives and their use as agonists or antagonists of an adenosine receptor |
| 07/29/2009 | EP2081923A1 Certain substituted amides, method of making, and method of use thereof |
| 07/29/2009 | EP2081897A1 Isoindol derivatives as ep4 receptor agonists |
| 07/29/2009 | EP2081565A2 Cinnamic acid, vanillic acid and benzofuran derivatives for use in the treatment of inflammation and cancer |
| 07/29/2009 | EP1931679A4 Analogs of salinosporamide a |
| 07/29/2009 | EP1686119B1 Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors |
| 07/29/2009 | EP1558277A4 Treatment of inflammatory bowel disease |
| 07/29/2009 | EP1435910B1 Novel cyclosporin analog microemulsion preconcentrates |
| 07/29/2009 | EP1406608B1 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 07/29/2009 | EP1397357B1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 07/29/2009 | EP1347805B1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/29/2009 | EP1261601B1 Substituted indoles for modulating nfkb activity |
| 07/29/2009 | CN101491536A Therapeutically useful synthetic oligonucleotides |
| 07/29/2009 | CN101491520A Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 07/29/2009 | CN100519554C CCR5 antagonists for treating aids |
| 07/29/2009 | CN100519552C Pyrazole compounds |
| 07/29/2009 | CN100519539C N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/29/2009 | CN100519528C Compounds with analgesic effect |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/29/2009 | CN100518752C Capsule for alleviating pains of neck, shoulder waist and leg |
| 07/29/2009 | CN100518747C Matrix metalloprotease inhibitor |
| 07/29/2009 | CN100518741C Pregnane steroids for use in the treatment of cns dysfunction |
| 07/28/2009 | US7566767 Synthetic peptides and methods of use for autoimmune disease therapies |
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/28/2009 | US7566723 1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use |
| 07/28/2009 | US7566694 Anti-pathogen treatments |
| 07/28/2009 | US7566566 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
| 07/28/2009 | US7566539 Anti-CCR2 antibodies and methods of use therefor |
| 07/28/2009 | US7566450 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulins for use in treatment and prevention of skin disorders |
| 07/28/2009 | CA2462453C Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| 07/28/2009 | CA2413883C Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation |
| 07/28/2009 | CA2387787C Nutritional composition for treating inflammatory bowel diseases |
| 07/28/2009 | CA2377174C Oral administration forms for administering a fixed tramadol and diclofenac combination |
| 07/28/2009 | CA2316447C Rantes mutants and therapeutic applications thereof |
| 07/28/2009 | CA2304899C New use of selective serotonin reuptake inhibitors for treatment of human patients with chest pain of non-cardiac origin or with gastro-esophageal reflux disease |
| 07/23/2009 | WO2009091874A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/23/2009 | WO2009091760A1 Oxazolidine and thiazolidine selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/23/2009 | WO2009090623A1 Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological applications thereof |
| 07/23/2009 | WO2009090414A1 Compounds having crth2 antagonist activity |
| 07/23/2009 | WO2009090399A1 Indoles active on crth2 receptor |
| 07/23/2009 | WO2009090055A1 Substituted sulfonamide derivatives |
| 07/23/2009 | WO2009090054A1 Substituted sulfonamide derivatives |
| 07/23/2009 | WO2009043747A3 N-heterocyclic biaryl carboxamides as ccr receptor antagonists |
| 07/23/2009 | WO2009026158A3 Inflammation-regulating compositions and methods |
| 07/23/2009 | WO2008033069A8 Selective chemokine modulation |
| 07/23/2009 | WO2007092939A8 Antigenic gm-csf peptides and antibodies to gm-csf |
| 07/23/2009 | US20090186947 Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride |
| 07/23/2009 | US20090186942 Novel nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 07/23/2009 | US20090186914 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 07/23/2009 | US20090186911 (RS)-S-[3-({[6-Bromo-4-(isopropylamino)quinazolin-7-yl]oxy}methyl)phenyl] N-(ethoxycarbonyl)-S-ethylsulphoximide, used for the treatment of chronic inflammatory diseases, such as rheumatoid arthritis, Crohn's disease, asthma and multiple sclerosis |
| 07/23/2009 | US20090186898 Inhibitors of bruton's tyrosine kinase |
| 07/23/2009 | US20090186895 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 07/23/2009 | US20090186889 Spiro-substituted pyrrolopyrimidines |
| 07/23/2009 | US20090186883 Stable Aqueous Suspension |
| 07/23/2009 | US20090186882 Cgrp receptor antagonists |
| 07/23/2009 | US20090186881 1(R)-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-[4-(tetrahydropyran-4-yl)-piperazin-1-yl]-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl); calcitonin gene related peptide antagonist; analgesic, antidiabetic agent; migraine or cluster headaches, non-insulin-dependent diabetes |
| 07/23/2009 | US20090186875 Dihydrothienopyrimidines, suitable for the treatment of respiratory, gastrointestinal, inflammatory, nervous system disorders and/or cancer |
| 07/23/2009 | US20090186850 Peritoneal dialysis method |
| 07/23/2009 | US20090186820 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 07/23/2009 | US20090186109 Parthenolide free bioactive ingredients from feverfew (tanacetum parthenium) and processes for their production |
| 07/23/2009 | US20090186086 Solid multilayer oral dosage forms |
| 07/23/2009 | US20090186082 Method of manufacturing modified release dosage forms |
| 07/23/2009 | US20090186030 Antibodies that bind both bcma and taci |
| 07/23/2009 | US20090186021 Methods of preventing or treating inflammatory or autoimmune disorders by administering CD2 antagonists in combination with other prophylactic or therapeutic agents |
| 07/23/2009 | US20090186010 Methods for the identification of ikkalfa function and other genes useful for treatment of inflammatory diseases |
| 07/23/2009 | US20090185997 Methods of suppressing microglial activation and systemic inflammatory responses |
| 07/23/2009 | CA2712269A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/23/2009 | CA2712266A1 Substituted sulfonamide derivatives |
| 07/23/2009 | CA2712265A1 Substituted sulfonamide derivatives |
| 07/23/2009 | CA2712190A1 Oxazolidine and thiazolidine selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/23/2009 | CA2712141A1 Preparation and enantiomeric separation of 7-(3-pyridinyl)-1,7-diazaspiro[4.4] nonane and novel salt forms of the racemate and enantiomers |
| 07/23/2009 | CA2712017A1 Compounds having crth2 antagonist activity |
| 07/23/2009 | CA2711931A1 Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological applications thereof |
| 07/23/2009 | CA2618380A1 Feed additive and uses thereof |
| 07/22/2009 | EP2081028A1 Use of a polypeptide to detect, prevent or treat a pathological state associated with a degenerative, neurological, autoimmune illness |
| 07/22/2009 | EP2080757A1 Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
| 07/22/2009 | EP2080525A1 Remodeling and Glycoconjugation of Peptides |
| 07/22/2009 | EP2080504A2 Topical composition comprising n-acetylaldosamines or n-acetylamino acids |
| 07/22/2009 | EP2079744A1 Imidazopyridazines as pi3k lipid kinase inhibitors |
| 07/22/2009 | EP2079731A1 Novel substituted piperidyl-propane-thiols |
| 07/22/2009 | EP2079725A1 Piperidyl-propane-thiol ccr3 modulators |
| 07/22/2009 | EP2079698A1 Caspase inhibitors based on pyridazinone scaffold |
| 07/22/2009 | EP2079691A1 Substituted indeno[1,2-b]indole derivatives as novel inhibitors of protein kinase ck2 and their use as tumour therapeutic agents, cytostatics and diagnostic aids |
| 07/22/2009 | EP2079676A1 Salts of dihydroxyanthraquinone carboxylic acids and their therapeutic use |
| 07/22/2009 | EP2079485A2 Phenylpropionamide compounds and the use thereof |
| 07/22/2009 | EP2079468A1 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 07/22/2009 | EP1648452B1 2-imino-4-(thio)oxo-5-polycyclovinylazolines for use as pi3 kinase inhibitors |
| 07/22/2009 | EP1605040B1 Monocyte-origin multipotent cell momc |
| 07/22/2009 | EP1492761B1 Amino acids with affinity for the alpha-2-delta-protein |
| 07/22/2009 | EP1453528B1 Compositions containing curcuma extracts for the treatment of neurocerebrovascular disorders |
| 07/22/2009 | EP1392680B1 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3 |